FR2138011B1 - - Google Patents

Info

Publication number
FR2138011B1
FR2138011B1 FR727217600A FR7217600A FR2138011B1 FR 2138011 B1 FR2138011 B1 FR 2138011B1 FR 727217600 A FR727217600 A FR 727217600A FR 7217600 A FR7217600 A FR 7217600A FR 2138011 B1 FR2138011 B1 FR 2138011B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR727217600A
Other languages
French (fr)
Other versions
FR2138011A1 (en:Method
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Smith Kline & French Laboratories Ltd
GlaxoSmithKline LLC
Original Assignee
Smith Kline & French Laboratories Ltd
GlaxoSmithKline LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smith Kline & French Laboratories Ltd, GlaxoSmithKline LLC filed Critical Smith Kline & French Laboratories Ltd
Publication of FR2138011A1 publication Critical patent/FR2138011A1/fr
Application granted granted Critical
Publication of FR2138011B1 publication Critical patent/FR2138011B1/fr
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0068—Rumen, e.g. rumen bolus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Fodder In General (AREA)
FR727217600A 1971-05-18 1972-05-17 Expired FR2138011B1 (en:Method)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US14449971A 1971-05-18 1971-05-18

Publications (2)

Publication Number Publication Date
FR2138011A1 FR2138011A1 (en:Method) 1972-12-29
FR2138011B1 true FR2138011B1 (en:Method) 1973-07-13

Family

ID=22508878

Family Applications (1)

Application Number Title Priority Date Filing Date
FR727217600A Expired FR2138011B1 (en:Method) 1971-05-18 1972-05-17

Country Status (10)

Country Link
AU (1) AU470023B2 (en:Method)
BE (1) BE783321A (en:Method)
CA (1) CA997677A (en:Method)
DE (1) DE2224390A1 (en:Method)
ES (1) ES402545A1 (en:Method)
FR (1) FR2138011B1 (en:Method)
GB (1) GB1330829A (en:Method)
IE (1) IE36335B1 (en:Method)
NL (1) NL7206328A (en:Method)
ZA (1) ZA722664B (en:Method)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4137300A (en) * 1976-08-20 1979-01-30 Ciba-Geigy Corporation Sustained action dosage forms
GB2093348B (en) * 1981-02-23 1984-09-12 Leo Pharm Prod Ltd Pharmaceutical composition for implantation
NZ204861A (en) * 1982-07-20 1986-10-08 Nat Res Dev Sustained release device:trace element incorporated in cement
FR2560768A1 (fr) * 1984-03-07 1985-09-13 Crb Virbac Sa Dispositif a liberation programmee
NZ234227A (en) * 1989-06-30 1991-08-27 Smithkline Beecham Corp Delayed release dosage form
GB8915716D0 (en) * 1989-07-08 1989-08-31 Coopers Animal Health Pharmaceutical compositions
US5190760A (en) * 1989-07-08 1993-03-02 Coopers Animal Health Limited Solid pharmaceutical composition
USD398395S (en) 1991-12-23 1998-09-15 Glaxo Wellcome Inc. Pharmaceutical tablet
USD376847S (en) 1992-06-30 1996-12-24 Burroughs Wellcome Co. Pharmaceutical tablet
NZ518739A (en) 1999-11-02 2004-12-24 Depomed Inc Pharmacological inducement of the fed mode for enhanced drug administration to the stomach
PT1251832E (pt) 2000-02-04 2007-01-31 Depomed Inc Forma de dosagem constituída por invólucro-e-núcleo que conduz a uma libertação do fármaco de ordem zero
US6723340B2 (en) 2001-10-25 2004-04-20 Depomed, Inc. Optimal polymer mixtures for gastric retentive tablets
CA2409552A1 (en) 2001-10-25 2003-04-25 Depomed, Inc. Gastric retentive oral dosage form with restricted drug release in the lower gastrointestinal tract
US6682759B2 (en) 2002-02-01 2004-01-27 Depomed, Inc. Manufacture of oral dosage forms delivering both immediate-release and sustained-release drugs
US20050013863A1 (en) 2003-07-18 2005-01-20 Depomed, Inc., A Corporation Of The State Of California Dual drug dosage forms with improved separation of drugs
CN104523636B (zh) * 2014-12-25 2017-07-18 昆明振华制药厂有限公司 一种呋喃唑酮缓释片及其制备方法
US12251208B2 (en) * 2020-11-30 2025-03-18 International Business Machines Corporation Time controlled medication
PT4037666T (pt) 2020-12-08 2024-06-25 Ruminant Biotech Corp Ltd Aperfeiçoamentos de dispositivos e métodos para administração de substâncias a animais
WO2025029158A1 (en) * 2023-08-01 2025-02-06 Ruminant Biotech Corp Limited Improved bolus designs for administration to a ruminant animal and uses thereof

Also Published As

Publication number Publication date
IE36335B1 (en) 1976-10-13
ES402545A1 (es) 1975-04-01
CA997677A (en) 1976-09-28
ZA722664B (en) 1973-01-31
IE36335L (en) 1972-11-18
FR2138011A1 (en:Method) 1972-12-29
AU4230972A (en) 1973-11-22
AU470023B2 (en) 1976-03-04
DE2224390A1 (de) 1973-12-13
GB1330829A (en) 1973-09-19
BE783321A (fr) 1972-11-10
NL7206328A (en:Method) 1972-11-21

Similar Documents

Publication Publication Date Title
FR2138011A1 (en:Method)
CS157132B2 (en:Method)
AU2658571A (en:Method)
CS170848B1 (en:Method)
AU452907B2 (en:Method)
CS157775B1 (en:Method)
CS154406B1 (en:Method)
CS166102B1 (en:Method)
CS169853B1 (en:Method)
CS175569B1 (en:Method)
CS163879B1 (en:Method)
CS149008B1 (en:Method)
CS173703B1 (en:Method)
CS155457B1 (en:Method)
CS151814B1 (en:Method)
CS153113B1 (en:Method)
CS167920B2 (en:Method)
CS173069B1 (en:Method)
CS150403B1 (en:Method)
CS163444B1 (en:Method)
CS156782B1 (en:Method)
AU2880771A (en:Method)
CS149522B1 (en:Method)
CS152844B1 (en:Method)
BG23426A1 (en:Method)